Company Name

Industry

Location

Revenue

Employees

KV Pharmaceutical

Pharmaceuticals

United States, Missouri

$250M to $500M

51-200

Salix Pharma

Pharmaceuticals

United States, North Carolina

$250M to $500M

51-200

Vanigent

Pharmaceuticals

United States, Georgia

$250M to $500M

51-200

US Script

Pharmaceuticals

United States, California

$100M to $250M

51-200

Pharma Logistics

Pharmaceuticals

United States, Illinois

$100M to $250M

51-200

Catalyst Pharmaceuticals

Pharmaceuticals

United States, Florida

$100M to $250M

51-200

Paratek Pharmaceuticals

Pharmaceuticals

United States, Massachusetts

$100M to $250M

51-200

Aytu BioPharma

Pharmaceuticals

United States, Colorado

$100M to $250M

51-200

DaVita Clinical Research

Pharmaceuticals

United States, Minnesota

$100M to $250M

51-200

The Mentholatum Company

Pharmaceuticals

United States, New York

$100M to $250M

51-200

Iroko Pharmaceuticals

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

51-200

Franck's Lab

Pharmaceuticals

United States, Florida

$100M to $250M

51-200

Ferndale Laboratories

Pharmaceuticals

United States, Michigan

$100M to $250M

51-200

Sheffield Pharmaceuticals

Pharmaceuticals

United States, Connecticut

$100M to $250M

51-200

Xcelience

Pharmaceuticals

United States, Florida

$100M to $250M

51-200

ISPE

Pharmaceuticals

United States, Maryland

$100M to $250M

51-200

Octapharma USA

Pharmaceuticals

United States, New Jersey

$100M to $250M

51-200

Phil

Pharmaceuticals

United States, California

$100M to $250M

51-200

Natural Alternatives International

Pharmaceuticals

United States, California

$100M to $250M

51-200

Tapemark

Pharmaceuticals

United States, Minnesota

$100M to $250M

51-200